IARC revised its carcinogenicity evaluations website (Volumes 1-123)

 

25 February, 2019.
(Revised 8 March, 2019.)

The International Agency for Research on Cancer (IARC), the cancer agency of the World Health Organization, revised its carcinogenicity evaluations website on February 22, 2019.
https://monographs.iarc.fr/agents-classified-by-the-iarc/


This revision is to notify publication of the online version of "IARC Monographs Volume 119: Some Chemicals That Cause Tumours of the Urinary Tract in Rodents".
 
There is no new agent added, and no change in the carcinogenicity categories for existing agents including EMFs.

Note by JEIC:
Following update of IARC Monographs Preamble and elimination of classification of "Group 4: Probably not carcinogenic to humans", Caprolactam, only one agent formerly classified as Group 4, was moved to "Group 3: Not classifiable as to its carcinogenicity to humans".
Related information: